Physician profile
Brian G Loder
NPI 1184629180
$853,937.67
in general payments reported to CMS, 2019-2025
33 companies · $324K in 2025
The $324K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $37K · 2021: $60K · 2022: $83K · 2023: $120K · 2024: $171K · 2025: $324K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $302K · Royalty Or License: $259K · Travel and Lodging: $45K · Food and Beverage: $8,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $301,527.88 |
| Royalty Or License | $259,133.09 |
| Travel and Lodging | $45,087.99 |
| Food and Beverage | $8,835.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $440,237.22 | 2019-2025 | Nexis, Peca Bunion Correction System, Pecaplasty |
| Treace Medical Concepts, INC. | $365,134.27 | 2023-2025 | |
| Medical Device Business Services, INC. | $40,180.25 | 2019-2020 | |
| Synthes USA Products LLC | $3,616.71 | 2019 | |
| Wright Medical Technology, INC. | $1,888.98 | 2019 | |
| Stryker Corporation | $480.98 | 2022-2025 | Hoffmann, Prophecy, Flexband |
| Nevro Corp. | $418.47 | 2022-2024 | Senza |
| Depuy Synthes Sales INC. | $349.59 | 2019-2025 | Gryphon Orthocord, Fms |
| Smith+Nephew, INC. | $310.23 | 2019-2025 | Collagenase Santyl |
| Organogenesis INC. | $268.31 | 2021-2025 | Simplimax |
| Medshape, INC. | $133.63 | 2023 | |
| Trilliant Surgical LLC. | $112.85 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Minimally Invasive Bunion Plate, Left |
| Hartmann USA, INC. | $94.32 | 2021-2025 | Zetuvit Plus 10x10 P10, Zetuvit Plus |
| Zimmer Biomet Holdings, INC. | $68.61 | 2020-2025 | Tapestry, Anchor Bolt, Juggerknotless Soft Anchor |
| Heron Therapeutics, INC. | $58.79 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $55.69 | 2024-2025 | Activ.A.C. |
| Abbvie INC. | $54.55 | 2022-2023 | |
| Paragon 28, INC. | $52.47 | 2022-2025 | Monster, Apex 3d |
| Misonix INC | $52.04 | 2019-2021 | |
| Bioventus LLC | $49.68 | 2020-2022 | |
| Globus Medical, INC. | $48.43 | 2025 | Senza |
| Horizon Therapeutics Plc | $46.20 | 2019-2022 | |
| Integra Lifesciences Corporation | $40.72 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Amgen INC. | $37.13 | 2024-2025 | Krystexxa |
| Mimedx Group, INC. | $22.71 | 2024 | |
| Orthofix Medical, INC. | $20.49 | 2025 | Physio-Stim |
| Baxter Healthcare | $19.49 | 2024 | Surgical Tools |
| Pinnacle, INC | $19.23 | 2023 | |
| Kerecis Limited | $18.30 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Cashflow Solutions, LLC | $17.50 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Paratek Pharmaceuticals, INC. | $17.12 | 2022 | |
| Aroa Biosurgery Incorporated | $12.71 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$55,650.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Loder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.